Medical College of Wisconsin Physician Scientist Immersion Program

威斯康星医学院医师科学家浸入式项目

基本信息

  • 批准号:
    10591714
  • 负责人:
  • 金额:
    $ 19.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

We have a unique opportunity to recruit, train, and retain promising physician-scientist candidates in academic medicine and intend to reverse the troubling losses from the physician-scientist pool. Using evidence-based techniques, we designed the Medical College of Wisconsin Physician-Scientist Immersion Program (MCW-PSIP) to focus on cultivating and maximizing local interest in careers as a physician-scientist in the Departments of Medicine (internal medicine), Surgery, Anesthesia and Pediatrics. Resident trainees will be immersed in a well- resourced and supportive program that is designed with specific milestones, training, and metrics for both trainees and mentors and will lead to participant eligibility for certification by the American Board of Medical Specialties. The MCW-PSIP is designed to train residents with a wide range of prior research experience, from those with minimal prior research exposure to those with prior Ph.D. training. Our research training program provides 23-24 months of enrollment in research blocks to fulfill programmatic requirements and expectations and overcome challenges faced by all resident trainees as they begin laying the foundations for their academic careers. Our goal for the proposed MCW-PSIP is to provide critically needed intensive mentoring, instill the necessary research skills training, and provide all necessary support for resident-investigators to grow into and thrive as independent physician-scientists either in basic or clinical and translational research. Our approach during our first four funding years (R38HL143561) supports the success of MCW-PSIP’s methods, and lessons learned during that time have led programmatic expansion and enhancements more fully delineated in our application. In the short-term, the resident-investigator will acquire the knowledge and critical skills needed to lead and complete a research project and produce presentations and publications that will be necessary to successfully compete for a full range of training awards, including K38 and K08/K23 awards. Long-term, for our institution, this pathway will serve as a feeder for its sub-specialty programs in Medicine, Surgery, Anesthesia, and Pediatrics. We further expect long-term, successful candidates will join a cadre of physician-scientist junior faculty at MCW or another academic institution in the U.S. Our proposal has two specific aims: Aim 1: To expand, recruit, and execute the MCW Internal Medicine Physician-Scientist Immersion Program for the development of physician-scientists through the R38 mechanism Aim 2: To quantify the success and challenges of the MCW Internal Medicine Physician Scientist Program through benchmarking, milestones, surveys, and expert review 1
我们有一个独特的机会来招募,培训和保留有前途的身体科学家候选人 药物并打算扭转物理科学家池的令人不安的损失。使用基于证据的 技术,我们设计了威斯康星州医学院医师科学家浸入式计划(MCW-PSIP) 专注于培养和最大化当地对职业的兴趣 医学(内科),手术,麻醉和儿科。居民学员将沉浸在一个井中 具有特定里程碑,培训和指标的资源和支持的计划 受训者和导师,将导致美国医疗委员会的参与资格获得认证 专业。 MCW-PSIP旨在培训具有多种先前研究经验的居民,从 那些对先前博士学位的研究暴露最少的研究。训练。我们的研究培训计划 提供23-24个月的研究块入学,以满足程序要求和期望 并克服所有居民学员开始为学术奠定基础时面临的挑战 职业。我们提出的MCW-PSIP的目标是提供迫切需要的密集型心理,灌输 必要的研究技能培训,并为居民评估者提供所有必要的支持,使其成长为 在基础或临床和翻译研究中以独立的身体科学家的身份壮成长。我们的方法 在我们的前四年(R38HL143561)中,支持MCW-PSIP的成功和课程 在那段时间里,学到的领导了程序扩展和增强,在我们的 应用。在短期内,居民评估者将获得所需的知识和关键技能 领导并完成研究项目和生产演示和出版物,这是必要的 成功竞争了包括K38和K08/K23奖项在内的全部培训奖。长期,为我们 机构,这一途径将对医学,手术,麻醉的亚专业计划更为有益, 和儿科。我们进一步期望长期,成功的候选人将加入一群身体科学家的干部 MCW的教师或美国其他学术机构 我们的建议有两个具体的目标: 目标1:扩展,招募和执行MCW内科医师浸入式计划 通过R38机制的身体科学家的发展 目标2:量化MCW内科医师计划的成功和挑战 通过基准测试,里程碑,调查和专家评论 1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY EAPEN其他文献

MARY EAPEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY EAPEN', 18)}}的其他基金

A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
  • 批准号:
    10388261
  • 财政年份:
    2019
  • 资助金额:
    $ 19.51万
  • 项目类别:
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
  • 批准号:
    10599276
  • 财政年份:
    2019
  • 资助金额:
    $ 19.51万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10270068
  • 财政年份:
    2018
  • 资助金额:
    $ 19.51万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10912972
  • 财政年份:
    2018
  • 资助金额:
    $ 19.51万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10757806
  • 财政年份:
    2018
  • 资助金额:
    $ 19.51万
  • 项目类别:
Stimulating Access to Research in Residency (StARR)
促进住院医师研究的机会(StARR)
  • 批准号:
    10202706
  • 财政年份:
    2018
  • 资助金额:
    $ 19.51万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10934820
  • 财政年份:
    2018
  • 资助金额:
    $ 19.51万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9127357
  • 财政年份:
    2015
  • 资助金额:
    $ 19.51万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9532936
  • 财政年份:
    2015
  • 资助金额:
    $ 19.51万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9324354
  • 财政年份:
    2015
  • 资助金额:
    $ 19.51万
  • 项目类别:

相似海外基金

Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10870632
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10671023
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
The Role of the Aging Brain-Heart-Immune Axis in Postoperative Delirium
老化的脑-心-免疫轴在术后谵妄中的作用
  • 批准号:
    10704763
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10521860
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder
阿尔茨海默病和术后神经认知障碍的血液 DNA 甲基化生物标志物
  • 批准号:
    10667556
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了